mounting evidence suggests that reducing the concentration of triglyceride-rich lipoprotein , which influences the production of the possibly atherogenic intermediate density lipoprotein ( idl ) , might diminish the circulating level of potentially atherogenic lipoproteins .
C0065063
intermediate density lipoprotein
C0023820
circulating